The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Closed claims complete the longitudinal patient journey in Truveta Data, enabling regulatory grade safety and effectiveness ...

In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed ...

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...

Private equity investors in health care and life sciences must navigate a complex and shifting landscape influenced by regulatory and policy ...

The technology to leverage healthcare data exists. The problem, according to Highlander Health, is outdated structures and ...

Further, many biologics are manufactured using biotechnology. CDER promotes and protects the public's health by ensuring that all prescription and nonprescription drugs marketed in the United ...

Q4 2024 Earnings Call Transcript January 28, 2025 Operator: Good afternoon, and welcome to the Alexandria Real Estate Equities Fourth Quarter and Year-End 2024 Conference Call. All participants will ...

Biohaven stock hurdled its 50-day and 200-day lines Tuesday after the FDA granted its SCA treatment a speedier review time.

Pressure is mounting on the US Food and Drug Administration (FDA) to explain its decision to ignore an advisory committee's positive recommendation for the cancer vaccine Provenge. In the coming ...

Mounjaro (tirzepatide) is a prescription injection used to help manage blood sugar levels in adults with type 2 diabetes. Mounjaro may not be safe to use while pregnant or breastfeeding.

The Center for Tobacco Products (CTP) recently announced a proposed rule that would “make cigarettes and certain other ...